In earlier reports it has been shown that silencing of ELOVL1 reduced cell viability of breast cancer cells significantly [13] and that inhibition of ELOVL7 resulted in drastic attenuation of prostate cancer cell growth [35]. Here, ELOVL1 is linked to breast carcinoma.